Michael J. MORGAN
Formerly Chief Executive, The Wellcome Genome Campus, Hinxton, UK

Michael is a graduate of Trinity College, Dublin, and obtained his PhD (in Biochemistry) from Leicester University.   He joined the Wellcome Trust in 1983 and prior to his retirement was director of Research Partnerships & Ventures and chief executive of the Wellcome Trust Genome Campus in Cambridge.


He played a major role with Francis Collins and Ari Patrinos in the international coordination of the human genome project from 1994 until his retirement from the Trust in 2002.  He led the Trust team that initiated and developed the Wellcome Trust Genome Campus, at Hinxton, including the Sanger Centre and the European Bioinformatics Institute.  In 1996 he arranged the Bermuda meetings and was a major supporter of the Bermuda Principles of data release. 


During this period he lead the development of new enterprises such as DIAMOND, a  new third generation synchrotron, a  partnership with the UK government; the SNPs Consortium (TSC), a partnership of the Trust and 12 private companies, and the Structural Genomics Consortium.


These partnerships follow the Bermuda Principles and release their data into the public domain as early as possible and with no restrictions on their use.


Michael was Chief Scientific Officer of Genome Canada from 2006 to 2009 where he instituted a new consultative process to determine strategic priorities for Canadian government investments in genomic, proteomic, and allied research programmes.  He retired in 2009.